Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Korman

Showing results (301-310 of 343) with videos related to

Pageof 35
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2013
Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattiiSharon C-A Chen, Tony M Korman, Monica A Slavin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2014
Emergence of a ribotype 244 strain of Clostridium difficile associated with severe disease and related to the epidemic ribotype 027 strainSze K Lim, Rhonda L Stuart, Kate E Mackin, et al.
The Lancet Regional Health. Western Pacific|February 13, 2025
Genomic interrogation of invasive group A <i>Streptococcus</i> (iGAS) epidemiology and COVID-19 impacts in Victoria, Australia: a 6-year retrospective studyJacqueline M Morris, Jake A Lacey, Kerrie Stevens, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 16, 2017
Herpes simplex virus-2 transmission following solid organ transplantation: Donor-derived infection and transplantation from prior organ recipientsNenad Macesic, Iain J Abbott, Matthew Kaye, et al.
Infection Control and Hospital Epidemiology|March 19, 2021
Clinical illness with viable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) virus presenting 72 days after infection in an immunocompromised patientCarly M Hughes, Gareth P Gregory, Anna B Pierce, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 2004
Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibilityBenjamin P Howden, Peter B Ward, Patrick G P Charles, et al.
Journal of Clinical Microbiology|July 18, 2014
Genetic and molecular predictors of high vancomycin MIC in Staphylococcus aureus bacteremia isolatesNatasha E Holmes, John D Turnidge, Wendy J Munckhof, et al.
Plastic and Reconstructive Surgery|May 9, 2014
A randomized controlled trial of the embrace advanced scar therapy device to reduce incisional scar formationMichael T Longaker, Rod J Rohrich, Lauren Greenberg, et al.
Plos One|July 23, 2013
Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010-11 seasons: a test-negative observational studyAllen C Cheng, Mark Holmes, Louis B Irving, et al.
Clinical Cardiology|March 24, 2018
Stem-cell therapy in ST-segment elevation myocardial infarction with reduced ejection fraction: A multicenter, double-blind randomized trialJosé C Nicolau, Remo H M Furtado, Suzana A Silva, et al.
Pageof 35

Showing results (301-310 of 343) with videos related to

Sort By:
Pageof 35
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2013
Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattiiSharon C-A Chen, Tony M Korman, Monica A Slavin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2014
Emergence of a ribotype 244 strain of Clostridium difficile associated with severe disease and related to the epidemic ribotype 027 strainSze K Lim, Rhonda L Stuart, Kate E Mackin, et al.
The Lancet Regional Health. Western Pacific|February 13, 2025
Genomic interrogation of invasive group A <i>Streptococcus</i> (iGAS) epidemiology and COVID-19 impacts in Victoria, Australia: a 6-year retrospective studyJacqueline M Morris, Jake A Lacey, Kerrie Stevens, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 16, 2017
Herpes simplex virus-2 transmission following solid organ transplantation: Donor-derived infection and transplantation from prior organ recipientsNenad Macesic, Iain J Abbott, Matthew Kaye, et al.
Infection Control and Hospital Epidemiology|March 19, 2021
Clinical illness with viable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) virus presenting 72 days after infection in an immunocompromised patientCarly M Hughes, Gareth P Gregory, Anna B Pierce, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 2004
Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibilityBenjamin P Howden, Peter B Ward, Patrick G P Charles, et al.
Journal of Clinical Microbiology|July 18, 2014
Genetic and molecular predictors of high vancomycin MIC in Staphylococcus aureus bacteremia isolatesNatasha E Holmes, John D Turnidge, Wendy J Munckhof, et al.
Plastic and Reconstructive Surgery|May 9, 2014
A randomized controlled trial of the embrace advanced scar therapy device to reduce incisional scar formationMichael T Longaker, Rod J Rohrich, Lauren Greenberg, et al.
Plos One|July 23, 2013
Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010-11 seasons: a test-negative observational studyAllen C Cheng, Mark Holmes, Louis B Irving, et al.
Clinical Cardiology|March 24, 2018
Stem-cell therapy in ST-segment elevation myocardial infarction with reduced ejection fraction: A multicenter, double-blind randomized trialJosé C Nicolau, Remo H M Furtado, Suzana A Silva, et al.
Pageof 35